biologic drugs market

Global Biologic Drugs Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

  • Published Date: 2020-12-23
  • Report ID: 32203
  • Pages: 108
  • Format: prudent report format

Summary

World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.

Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.

XYZResearchs analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.

This research report indicated that the global Biologic Drugs market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.

Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Biologic Drugs Market by XYZResearch Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Biologic Drugs Market
Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Pfizer
Amgen
Sanofi
Novartis
Eli Lilly
Amgen
...
Major Type of Biologic Drugs Covered in XYZResearch report:
Humira
Remicade
Rituxan
Enbrel
Lantus
Avastin
Herceptin
Others
Application Segments Covered in XYZResearch Market
Diabetes
Inflammation
Auto-Immune Diseases
Blood Diseases
Cardiovascular Diseases
Others

For any other requirements, please feel free to contact us and we will provide you customized report.


Table of Contents

Global Biologic Drugs Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Humira -Product Introduction and Major Manufacturers
1.1.2 Remicade -Product Introduction and Major Manufacturers
1.1.3 Rituxan -Product Introduction and Major Manufacturers
1.1.4 Enbrel -Product Introduction and Major Manufacturers
1.1.5 Lantus -Product Introduction and Major Manufacturers
1.1.6 Avastin -Product Introduction and Major Manufacturers
1.1.7 Herceptin -Product Introduction and Major Manufacturers
1.1.8 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Biologic Drugs Status and Prospect (2015-2026)
2.1.1 China Biologic Drugs Market Size and Growth Rate (2015-2026)
2.1.2 China Biologic Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Biologic Drugs Status and Prospect (2015-2026)
2.2.1 EU Biologic Drugs Market Size and Growth Rate (2015-2026)
2.2.2 EU Biologic Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Biologic Drugs Status and Prospect (2015-2026)
2.3.1 USA Biologic Drugs Market Size and Growth Rate (2015-2026)
2.3.2 USA Biologic Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Biologic Drugs Status and Prospect (2015-2026)
2.4.1 Japan Biologic Drugs Market Size and Growth Rate (2015-2026)
2.4.2 Japan Biologic Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Biologic Drugs Status and Prospect (2015-2026)
2.5.1 India Biologic Drugs Market Size and Growth Rate (2015-2026)
2.5.2 India Biologic Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Biologic Drugs Status and Prospect (2015-2026)
2.6.1 Southeast Asia Biologic Drugs Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Biologic Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Biologic Drugs Status and Prospect (2015-2026)
2.7.1 South America Biologic Drugs Market Size and Growth Rate (2015-2026)
2.7.2 South America Biologic Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Biologic Drugs Status and Prospect (2015-2026)
2.8.1 Biologic Drugs Market Size and Growth Rate (2015-2026)
2.8.2 Biologic Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Biologic Drugs Market Assessment by Segment
3.1 Global Biologic Drugs Capacity and Growth Rate
3.2 Global Biologic Drugs Sales by Type
3.3 Global Biologic Drugs Sales Revenue by Type
3.4 Global Biologic Drugs Consumption by Application
4 Global Biologic Drugs Market Assessment by Regions
4.1 Global Biologic Drugs Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Biologic Drugs Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Biologic Drugs Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Biologic Drugs Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Biologic Drugs Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Biologic Drugs Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Biologic Drugs Sales Market Share of Manufacturers (2019-2020)
6.3 Global Biologic Drugs Sales Revenue Market Share of Manufacturers (2019-2020)

7 Biologic Drugs Competitive Analysis
7.1 Roche
7.1.1 Roche Company Profiles
7.1.2 Roche Product Introduction
7.1.3 Roche Biologic Drugs Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Company Profiles
7.2.2 Abbott Laboratories Product Introduction
7.2.3 Abbott Laboratories Biologic Drugs Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Profiles
7.3.2 Johnson & Johnson Product Introduction
7.3.3 Johnson & Johnson Biologic Drugs Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Merck & Co.
7.4.1 Merck & Co. Company Profiles
7.4.2 Merck & Co. Product Introduction
7.4.3 Merck & Co. Biologic Drugs Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Pfizer
7.5.1 Pfizer Company Profiles
7.5.2 Pfizer Product Introduction
7.5.3 Pfizer Biologic Drugs Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Amgen
7.6.1 Amgen Company Profiles
7.6.2 Amgen Product Introduction
7.6.3 Amgen Biologic Drugs Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Sanofi
7.7.1 Sanofi Company Profiles
7.7.2 Sanofi Product Introduction
7.7.3 Sanofi Biologic Drugs Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Novartis
7.8.1 Novartis Company Profiles
7.8.2 Novartis Product Introduction
7.8.3 Novartis Biologic Drugs Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Eli Lilly
7.9.1 Eli Lilly Company Profiles
7.9.2 Eli Lilly Product Introduction
7.9.3 Eli Lilly Biologic Drugs Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Amgen
7.10.1 Amgen Company Profiles
7.10.2 Amgen Product Introduction
7.10.3 Amgen Biologic Drugs Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
8 Conclusion


CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.